Cross-Neutralization of a SARS-CoV-2 Antibody to a Functionally Conserved Site Is Mediated by Avidity
- The Scripps Research Inst., La Jolla, CA (United States). Dept. of Integrative Structural and Computational Biology; OSTI
- The Scripps Research Inst., La Jolla, CA (United States). Dept. of Integrative Structural and Computational Biology
- Univ. of Amsterdam (Netherlands). Amsterdam UMC. Dept. of Medical Microbiology
- Univ. of Amsterdam (Netherlands). Amsterdam UMC. Dept. of Medical Microbiology; Cornell Univ., Ithaca, NY (United States). Weill Medical College. Dept. of Microbiology and Immunology
- The Scripps Research Inst., La Jolla, CA (United States). Dept. of Integrative Structural and Computational Biology; The Scripps Research Inst., La Jolla, CA (United States). IAVI Neutralizing Antibody Center; The Scripps Research Inst., La Jolla, CA (United States). Consortium for HIV/AIDS Vaccine Development (CHAVD)
- The Scripps Research Inst., La Jolla, CA (United States). Dept. of Integrative Structural and Computational Biology. IAVI Neutralizing Antibody Center. Consortium for HIV/AIDS Vaccine Development (CHAVD). The Skaggs Institute for Chemical Biology
Most antibodies isolated from individuals with coronavirus disease 2019 (COVID-19) are specific to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, COVA1-16 is a relatively rare antibody that also cross-neutralizes SARS-CoV. Here, we determined a crystal structure of the COVA1-16 antibody fragment (Fab) with the SARS-CoV-2 receptor-binding domain (RBD) and negative-stain electron microscopy reconstructions with the spike glycoprotein trimer to elucidate the structural basis of its cross-reactivity. COVA1-16 binds a highly conserved epitope on the SARS-CoV-2 RBD, mainly through a long complementarity-determining region (CDR) H3, and competes with the angiotensin-converting enzyme 2 (ACE2) receptor because of steric hindrance rather than epitope overlap. COVA1-16 binds to a flexible up conformation of the RBD on the spike and relies on antibody avidity for neutralization. These findings, along with the structural and functional rationale for epitope conservation, provide insights for development of more universal SARS-like coronavirus vaccines and therapies.
- Research Organization:
- The Scripps Research Inst., La Jolla, CA (United States)
- Sponsoring Organization:
- USDOE Office of Science (SC), Basic Energy Sciences (BES)
- Grant/Contract Number:
- AC02-76SF00515
- OSTI ID:
- 1816211
- Journal Information:
- Immunity, Journal Name: Immunity Journal Issue: 6 Vol. 53; ISSN 1074-7613
- Publisher:
- Cell PressCopyright Statement
- Country of Publication:
- United States
- Language:
- English
Similar Records
Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies
Structural basis of a shared antibody response to SARS-CoV-2
Journal Article
·
Tue Jun 23 20:00:00 EDT 2020
· Cell
·
OSTI ID:1816377
Structural basis of a shared antibody response to SARS-CoV-2
Journal Article
·
Sun Jul 12 20:00:00 EDT 2020
· Science
·
OSTI ID:1816389